ArticleBlood advances2023

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes.

Rami S Komrokji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.